|
卵巢癌合并肾衰1例的治疗体会
|
Abstract:
[1] | B. S. Gostout, D. R. Pachman, R. Lechner, et al. Recognizing and treating ovarian cancer. Minnesota Medicine, 2012, 95(3): 40-42. |
[2] | 赵霞, 钟茜. 卵巢癌早期筛查的争议与展望[J]. 西部医学, 2009, 21(1): 1672-1673. |
[3] | K. Matsuo. Inferior vena cava filter placement and risk of he- matogenous distant metastasis in ovarian cancer. American Jour- nal of Clinical Oncology, 2013, 36(4): 362-736. |
[4] | NCCN. 2012 NCCN ovarian cancer including falopian tube cancer and primary peritoneal cancer clinical practice guidelnes. 2nd Edition, l MJ. NCCN, 2012. |
[5] | 易祥明. 急性肾衰竭血液透析的疗效观察[J]. 医学信息, 2009, 1(12): 94-95. |
[6] | B. L. Jaber. Apoptosis of leukocytes: Basic concepts and impli- cations in uremia. Kidney International Supplements, 2001, 78: S197-S205. |
[7] | J. Galloway. Remarks on hondgkin’s disease. British Medical Journal, 1922, 2(3234): 1201-1208. |
[8] | 顾勇. 肿瘤相关性肾损害[J]. 继续医学教育, 2006, 20(5): 52. |
[9] | 任玉卿, 姜振华, 史官茂等. 肿瘤合并肾损害35例临床分析[J]. 临床与实践, 2012, 16(32): 4228-4230. |
[10] | S. Horie. A case of inoperable advanced bile duct cancer treated effectively with combined chemotherapy of gemcitabine and S-1. Gan to Kagaku Ryoho, 2013, 40(2): 259-262. |
[11] | S. C. Weng. Malignant lymphoma of the kidney mimicking ra- pid progressive glomerulonephritis. Clinical Nephrology, 2010, 74(6): 480-484. |
[12] | D. J. Pinato. Evolving concepts in the management of drug re- sistant ovarian cancer: Dose dense chemotherapy and the rever- sal of clinical platinum resistance. Cancer Treat Reviews, 2013, 39(2): 153-160. |